Catalytic asymmetric synthesis of R207910
…, Y Shimizu, M Kanai, M Shibasaki
Index: Yamasaki, Shingo; Fujii, Kunihiko; Wada, Reiko; Kanai, Motomu; Shibasaki, Masakatsu Journal of the American Chemical Society, 2002 , vol. 124, # 23 p. 6536 - 6537
Full Text: HTML
Citation Number: 27
Abstract
The first asymmetric synthesis of a very promising antituberculosis drug candidate, R207910, was achieved by developing two novel catalytic transformations; a catalytic enantioselective proton migration and a catalytic diastereoselective allylation of an intermediate α-chiral ketone. Using 2.5 mol% of a Y-catalyst derived from Y (HMDS) 3 and the new chiral ligand 9, 1.25 mol% of p-methoxypyridine N-oxide (MEPO), and 0.5 mol% ...
Related Articles:
[Li, Shunxi; Wang, Jin-Xian; Wen, Xiaoliu; Ma, Xiaofang Tetrahedron, 2011 , vol. 67, # 5 p. 849 - 855]
[Yanagisawa, Akira; Inoue, Hirokuni; Morodome, Miwa; Yamamoto, Hisashi Journal of the American Chemical Society, 1993 , vol. 115, # 22 p. 10356 - 10357]
[Grela, Karol; Tryznowski, Mariusz; Bieniek, Michal Tetrahedron Letters, 2002 , vol. 43, # 50 p. 9055 - 9059]
[Reetz, Manfred T.; Westermann, Juergen; Steinbach, Rainer; Wenderoth, Bernd; Peter, Roland; et al. Chemische Berichte, 1985 , vol. 118, # 4 p. 1421 - 1440]
[Reetz, M. T.; Wenderoth, B. Tetrahedron Letters, 1982 , vol. 23, # 50 p. 5259 - 5262]